Hepion Pharmaceuticals replaces auditor Grassi with Rosenberg Rich Baker Berman
The company said Grassi & Co. was dismissed effective Sept. 22, 2026, and Rosenberg Rich Baker Berman was hired to audit 2026 consolidated financial statements.
The company said Grassi & Co. was dismissed effective Sept. 22, 2026, and Rosenberg Rich Baker Berman was hired to audit 2026 consolidated financial statements.